Skye Bioscience, Inc. (SKYE)
2.17
-0.07
(-3.12%)
USD |
NASDAQ |
Aug 24, 16:00
2.13
-0.04
(-1.84%)
After-Hours: 06:10
Skye Bioscience Market Cap : 76.26M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 76.26M |
| August 21, 2026 | 78.72M |
| August 20, 2026 | 78.83M |
| August 19, 2026 | 86.00M |
| August 18, 2026 | 100.93M |
| August 17, 2026 | 116.71M |
| August 14, 2026 | 141.00M |
| August 13, 2026 | 152.10M |
| August 12, 2026 | 154.32M |
| August 11, 2026 | 152.07M |
| August 10, 2026 | 149.71M |
| August 07, 2026 | 146.03M |
| August 06, 2026 | 132.62M |
| August 05, 2026 | 157.92M |
| August 04, 2026 | 161.66M |
| August 03, 2026 | 164.25M |
| July 31, 2026 | 159.83M |
| July 30, 2026 | 163.15M |
| July 29, 2026 | 172.91M |
| July 28, 2026 | 172.88M |
| July 27, 2026 | 175.10M |
| July 24, 2026 | 183.28M |
| July 23, 2026 | 189.78M |
| July 22, 2026 | 179.99M |
| July 21, 2026 | 179.94M |
| Date | Value |
|---|---|
| July 20, 2026 | 183.79M |
| July 17, 2026 | 182.55M |
| July 16, 2026 | 176.73M |
| July 15, 2026 | 170.40M |
| July 14, 2026 | 174.34M |
| July 13, 2026 | 186.12M |
| July 10, 2026 | 193.99M |
| July 09, 2026 | 197.06M |
| July 08, 2026 | 197.65M |
| July 07, 2026 | 197.73M |
| July 06, 2026 | 197.73M |
| July 02, 2026 | 196.95M |
| July 01, 2026 | 189.83M |
| June 30, 2026 | 194.92M |
| June 29, 2026 | 188.42M |
| June 26, 2026 | 191.06M |
| June 25, 2026 | 199.07M |
| June 24, 2026 | 190.81M |
| June 23, 2026 | 196.71M |
| June 22, 2026 | 199.18M |
| June 18, 2026 | 198.76M |
| June 17, 2026 | 199.94M |
| June 16, 2026 | 201.88M |
| June 15, 2026 | 205.00M |
| June 12, 2026 | 221.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 85.67B |
| Viking Therapeutics, Inc. | 3.876B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Savara, Inc. | 1.142B |
Market Cap Related Metrics
| PEG Ratio | -0.0112 |
| Price | 2.17 |
| Earnings Yield | -469.1% |
| PEGY Ratio | -0.0112 |